Session Details

F050 Itch

Sat, Mar 9, 9:00 AM - 12:00 AM
Room 6D
2 CME Available Forum
View Map

DESCRIPTION

Chronic pruritus, arising idiopathically or in association with cutaneous or systemic disease, may be incapacitating. This session is meant for the clinician who wants to understand how itch arises and how best to approach itch management in different clinical scenarios, including itch associated with allergic, systemic, neuropathic and psychiatric disorders. Expert itch clinicians and researchers will explain advances in our understanding of itch pathophysiology and will communicate their experience in the diagnosis and management of challenging itches, including prurigo nodularis, neuropathic and psychogenic itch. Novel and pipeline therapies and devices for the management of chronic itch will be discussed.

LEARNING OBJECTIVES

1.

Categorize different types of chronic itch and utilize appropriate diagnostic tests in the evaluation of patients suffering form chronic pruritus.

2.

Incorporate neuromodulators, immunomodulators and alternative therapies into the management of patients with chronic itch.

3.

Describe new or pipeline agents to treat chronic itch.

SCHEDULE

9:00 AM

Introduction: Advances in Itch

Sarina Elmariah, MD, FAAD

9:10 AM

Updates in the Pathophysiology of Itch

Brian S Kim, MD, FAAD

9:35 AM

The Dermatologist’s Playbook for Chronic Itch

Shawn Kwatra, MD, FAAD

10:00 AM

Updates in Allergic Itch

Sarah Scott Chisolm, MD, FAAD

10:25 AM

Evolving pipeline for managment of itch

Gil Yosipovitch, MD

DIRECTOR

Sarina Elmariah, MD, FAAD

Sarina Elmariah, MD, FAAD

SPEAKERS

Sarah Scott Chisolm, MD, FAAD

Sarah Scott Chisolm, MD, FAAD

Brian S Kim, MD, FAAD

Brian S Kim, MD, FAAD

Shawn Kwatra, MD, FAAD

Shawn Kwatra, MD, FAAD

Gil Yosipovitch, MD

Gil Yosipovitch, MD

DISCLOSURES

Sarah Scott Chisolm, MD, FAAD

AbbVie – Advisory Board(Honoraria); Cara Therapeutics – Other(No Compensation Received); Galderma USA – Advisory Board(Honoraria); Incyte Corporation – Advisory Board(Honoraria); Kiniksa Pharmaceuticals, Ltd. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Novartis – Advisory Board(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria); Vifor Pharma – Advisory Board(Honoraria);

Sarina Elmariah, MD, FAAD

Eli Lilly – Other(Honoraria); Galderma Laboratories, LP – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria);

Brian S Kim, MD, FAAD

AbbVie – Consultant(Fees); Almirall – Advisory Board(Honoraria); Alys Pharmaceuticals – Stockholder Private Company(Stock); AstraZeneca – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Advisory Board(Honoraria); Evommune, Inc. – Consultant (1099 relationship)(Fees); Galderma – Consultant (1099 relationship)(Fees); Guidepoint Global, LLC – Consultant(Fees); Leo Pharma Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Locus Biosciences – Stockholder(Stock); Novartis – Advisory Board(Honoraria); Pfizer Inc. – Consultant(Honoraria); Recens Medical – Consultant(Fees); Regeneron – Consultant (1099 relationship)(Honoraria); Sanofi – Consultant(Fees); Septerna – Consultant (1099 relationship)(Fees);

Shawn Kwatra, MD, FAAD

AbbVie – Consultant(Honoraria); Amgen – Advisory Board(Honoraria); Arcutis Biotherapeutics – Advisory Board(Honoraria); Castle Biosciences, Inc – Consultant(Honoraria); Galderma – Investigator(Grants/Research Funding); Galderma USA – Consultant(Honoraria); Incyte Corporation – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Johnson and Johnson – Advisory Board(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Regeneron – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(Grants/Research Funding);

Gil Yosipovitch, MD

AbbVie – Advisory Board(Honoraria); Arcutis, Inc. – Advisory Board(Honoraria); Cara Therapeutics – Advisory Board(Honoraria); CeraVe – Advisory Board(Honoraria); Eli Lilly – Investigator(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria); escient – Investigator(Fees), Investigator(Grants/Research Funding); Galderma – Advisory Board(Honoraria); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); GSK – Advisory Board(Honoraria); Kamari Pharma – Consultant(Fees); Kiniksa Pharmaceuticals, Ltd. – Investigator(Grants/Research Funding); Maruho Co., Ltd – Speaker/Faculty Education(Fees); Novartis – Consultant(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pierre Fabre – Consultant(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); Vifor Pharma – Consultant(Fees);